PDF(Pubmed)
Abstract：
UNASSIGNED: Little is known about the prevalence and risks associated with transgender and gender diverse (TGD) persons\' misuse of prescription pain relievers (PPRs). This study explores the relationship between PPR misuse and various sociodemographic identities and experiences of discrimination in health care among TGD adults.
UNASSIGNED: TGD participants (n=595) were recruited in 2018 to participate in a cross-sectional statewide trans health survey through convenience sampling. Chi-square tests of independence and logistic regressions were conducted to explore associations between sociodemographics and experiences of discrimination among persons who had ever misused PPRs, or who had misused PPRs in the past year.
UNASSIGNED: Sociodemographics such as gender identity (odds ratio [OR]=0.44, p=0.01), race/ethnicity (OR=0.14, p<0.001), and sexual orientation influence TGD individuals likeliness of misusing PPRs (OR=0.40, p<0.001). Notably, those who were ever diagnosed with anxiety had a higher likeliness of having lifetime PPR misuse compared with those who were never diagnosed (OR=2.05, p=0.05), and those reporting past-year discrimination within the mental health care setting because of their gender identity were more than twice as likely to report past-year misuse than those who reported not experiencing it (OR=2.43, p=0.004).
UNASSIGNED: Certain subpopulations of TGD individuals may be at elevated risk of PPR misuse. It is imperative to acknowledge the impact of multimarginalized identities as well as differences across various identities and experiences within the TGD community while working to address non-PPR misuse.
UNASSIGNED: TGD participants (n=595) were recruited in 2018 to participate in a cross-sectional statewide trans health survey through convenience sampling. Chi-square tests of independence and logistic regressions were conducted to explore associations between sociodemographics and experiences of discrimination among persons who had ever misused PPRs, or who had misused PPRs in the past year.
UNASSIGNED: Sociodemographics such as gender identity (odds ratio [OR]=0.44, p=0.01), race/ethnicity (OR=0.14, p<0.001), and sexual orientation influence TGD individuals likeliness of misusing PPRs (OR=0.40, p<0.001). Notably, those who were ever diagnosed with anxiety had a higher likeliness of having lifetime PPR misuse compared with those who were never diagnosed (OR=2.05, p=0.05), and those reporting past-year discrimination within the mental health care setting because of their gender identity were more than twice as likely to report past-year misuse than those who reported not experiencing it (OR=2.43, p=0.004).
UNASSIGNED: Certain subpopulations of TGD individuals may be at elevated risk of PPR misuse. It is imperative to acknowledge the impact of multimarginalized identities as well as differences across various identities and experiences within the TGD community while working to address non-PPR misuse.
摘要：
■关于跨性别和性别多样化（TGD）人群滥用处方止痛药（PPR）的患病率和风险知之甚少。这项研究探讨了PPR滥用与TGD成年人在医疗保健中的各种社会人口统计学特征和歧视经验之间的关系。
■2018年招募了TGD参与者（n=595），通过便利抽样参加了全州横断面的跨健康调查。进行了独立性和逻辑回归的卡方检验，以探讨曾滥用PPR的人的社会人口统计学与歧视经历之间的关联，或者在过去一年中滥用PPRs的人。
■社会人口统计学，例如性别认同（比值比[OR]=0.44，p=0.01），种族/民族（OR=0.14，p<0.001），性取向影响TGD个体滥用PPR的可能性(OR=0.40，p<0.001)。值得注意的是,那些曾经被诊断为焦虑的人与那些从未被诊断的人相比，终生PPR滥用的可能性更高(OR=2.05，p=0.05)，那些在精神卫生保健机构中由于性别认同而报告过去一年歧视的人报告过去一年滥用的可能性是那些报告未经历滥用的人的两倍多(OR=2.43,p=0.004).
■TGD个体的某些亚群可能存在PPR误用的高风险。必须承认多重身份的影响以及TGD社区内各种身份和经验之间的差异，同时努力解决非PPR滥用问题。
■2018年招募了TGD参与者（n=595），通过便利抽样参加了全州横断面的跨健康调查。进行了独立性和逻辑回归的卡方检验，以探讨曾滥用PPR的人的社会人口统计学与歧视经历之间的关联，或者在过去一年中滥用PPRs的人。
■社会人口统计学，例如性别认同（比值比[OR]=0.44，p=0.01），种族/民族（OR=0.14，p<0.001），性取向影响TGD个体滥用PPR的可能性(OR=0.40，p<0.001)。值得注意的是,那些曾经被诊断为焦虑的人与那些从未被诊断的人相比，终生PPR滥用的可能性更高(OR=2.05，p=0.05)，那些在精神卫生保健机构中由于性别认同而报告过去一年歧视的人报告过去一年滥用的可能性是那些报告未经历滥用的人的两倍多(OR=2.43,p=0.004).
■TGD个体的某些亚群可能存在PPR误用的高风险。必须承认多重身份的影响以及TGD社区内各种身份和经验之间的差异，同时努力解决非PPR滥用问题。
